← Eichor
Condition: Intestinal Fibrosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Intestinal Fibrosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00001456
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162
Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
NA · 3 location(s) · Zhejiang University · NCT07252102
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA · 2 location(s) · Pichamol Jirapinyo, MD, MPH · NCT06138821
68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT07273188
Unravelling Intestinal Fibrosis in Ulcerative Colitis
Phase 2/Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06604273
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabe
NA · 2 location(s) · Rhode Island Hospital · NCT05723445
An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
Phase 1/Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05692024
Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor
NA · 15 location(s) · University Hospital, Bordeaux · NCT05937815
VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT07202910
AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease
Phase N/A · 5 location(s) · Minhu Chen · NCT06858553
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy
NA · 1 location(s) · Juergen Debus · NCT04094454
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07429864
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
NA · 3 location(s) · Melissa Pugliano-Mauro · NCT05408117
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
NA · 1 location(s) · Hunter Holmes Mcguire Veteran Affairs Medical Center · NCT06464952
Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
Phase 1/Phase 2 · 2 location(s) · Virginia Commonwealth University · NCT05548452
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Saint Pierre · NCT06814600
Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis
NA · 1 location(s) · Oslo University Hospital · NCT06284577
National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852
FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients
Phase 2 · 1 location(s) · Dalia Lartey · NCT06604260
Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis
NA · 1 location(s) · IRCCS San Raffaele · NCT06516237
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06252493
Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease
Phase N/A · 1 location(s) · University of Edinburgh · NCT07152431
Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)
Phase N/A · 2 location(s) · Medizinische Hochschule Brandenburg Theodor Fontane · NCT03052283
A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · 23 location(s) · King's College London · NCT06461208
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.